UTI Small Cap Fund · Regular · Growth
NAV
₹27.5342
as of 15 Jul 2026
Expense Ratio
1.85%
AUM
₹4,472 Cr
Lumpsum returns (CAGR)
- 1Y
- +2.98%
- 3Y
- +15.46%
- 5Y
- +14.82%
- Since Inception
- +4.02%
SIP returns (XIRR)
- 1Y
- +15.09%
- 3Y
- +10.92%
- 5Y
- +14.29%
- Since Inception
- +6.46%
Returns calculated from 06 May 2002 onwards due to a structural change in the scheme on that date. Earlier NAV history is preserved but excluded from multi-year return calculations. Periods spanning this date show —.
What history actually did — last 5 years (Jul 2021 – Jul 2026)
A ₹5,000 monthly SIP for the last 5 years (Jul 2021 – Jul 2026)
Real NAV backtest
A ₹5,000 monthly SIP would be worth ₹4,23,575 today — ₹3,00,000 invested, 14.2% XIRR.
₹3,00,000
Invested
₹4,23,575
Value today
14.2%
XIRR (p.a.)
A ₹1,00,000 lumpsum, the last 5 years (Jul 2021 – Jul 2026)
Real NAV backtest
₹1,00,000 invested 5 years ago would be ₹1,99,609 today (14.8% CAGR).
A regular withdrawal plan (SWP)
Real NAV backtest
A ₹10,00,000 corpus withdrawing ₹5,000/month since Jul 2021 would still hold ₹15,72,512.
Fund vs Benchmark (TRI)
Same SIP, benchmark total-return index
The same SIP would be worth ₹4,23,575 in this fund vs ₹4,45,283 in the benchmark — underperformance of ₹21,708.
Buying the worst day
Real NAV backtest
₹1,00,000 invested on the worst market day of the last 5 years (Jul 2021 – Jul 2026) (3 Jun 2024) would be ₹1,23,175 today (1.23×).
Historical simulation using actual published NAVs for the stated period. Past performance may or may not be sustained in the future. Not investment advice.
Risk Metrics
Trailing 1 year, annualised-0.00
Sharpe Ratio
-0.00
Alpha
0.48
Beta
-0.00
Sortino
17.76%
Std Dev
-18.94%
Max Drawdown
Performance Comparison
Sectoral allocation
as of 31 May 2026- Pharmaceuticals & Biotechnology9.32%
- Industrial Products8.23%
- Electrical Equipment7.22%
- Healthcare Services6.26%
- Banks6.13%
- Consumer Durables5.81%
- Chemicals & Petrochemicals5.81%
- Finance5.78%
- Capital Markets4.64%
- Commercial Services & Supplies4.62%
- Auto Components4.17%
- IT - Software4.00%
Each sector links to the mutual funds most exposed to it.
Thinking about UTI Small Cap Fund · Regular · Growth?
Talk to our AMFI-registered team — free, no pressure. We'll help you see if this fund fits your goals.
Fund Details
Available transactions
Portfolio holdings
- 1Td Power Systems Ltd.2.92%
- 2Karur Vysya Bank Ltd.2.55%
- 3Acutaas Chemicals Limited2.45%
- 4Navin Fluorine International L2.10%
- 5Aster Dm Healthcare Ltd2.02%
- 6Inox India Ltd1.89%
- 7Mtar Technologies Ltd1.86%
- 8Ujjivan Small Finance Bank Ltd1.84%
- 9City Union Bank1.74%
- 10Affle 3i Limited1.74%
Investment Objective
UTI Small Cap Fund · Regular · Growth aims to generate long-term capital appreciation by investing in small-cap companies — ranked 251st and below by market capitalisation. Small-cap funds offer higher growth potential but also carry higher volatility and risk compared to large-cap and mid-cap funds.
About This Fund
UTI Small Cap Fund · Regular · Growth is a Small Cap mutual fund offered by UTI Mutual Fund. The fund has been operational for over 25 years. It manages assets worth ₹4,472 Cr, reflecting investor confidence in the fund's strategy. It benchmarks its performance against Nifty Smallcap 250 TRI. The current expense ratio is 1.85%.
Who Should Invest?
- •Aggressive investors comfortable with significant short-term volatility
- •Investors with a long-term horizon of 7+ years who can ride out market cycles
- •Investors who understand that small-cap stocks can be highly volatile and are willing to stay invested for the long term
- •SIP investors who can benefit from rupee cost averaging during market fluctuations